Skip to main content

Table 3 Testing schedule of participants

From: Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial

Testing schedule Task Telephone screen Face-to-face screen Baseline(0 months) Midpoint(3 months) Endpoint(6 months) Follow-up 4 weeks after endpoint(7 months)
Screening assessment TICS-M X      
General medical history   X     
MoCA   X     
GDS   X     
RAVLT   X     
CogState® battery Identification taska    X X X  
One card learning testa    X X X  
Detection testb    X X X  
One back testb    X X X  
CogState® additional test Groton Maze learning testb    X X X  
Mood and fatigue outcome measures DASS-42b    X X X  
SHAIb    X X X  
FACIT-Fb    X X X  
Electrophysiological tasks Word list immediate and delayed recall tasksc    X   X  
Resting-state EEGc    X   X  
Equiprobable Go/NoGoc    X   X  
Safety and compliance measures FBC, E/LFT (bloods)b    X   X  
Adverse effectsb     X X X
Compliance and blinding     X X X
  1. aCo-primary outcome measures
  2. bSecondary outcome measures
  3. cEEG tasks will be completed by a subset of participants
  4. DASS-42 Depression, Anxiety, Stress Scale, EEG electroencephalography, E/LFT electrolyte and liver function test, FACIT-F Functional Assessment of Chronic Illness Therapy Fatigue Scale, FBC full blood count, GDS Geriatric Depression Scale, MoCA Montreal Cognitive Assessment, RAVLT Rey Auditory Verbal Learning Test, SHAI Short Health Anxiety Inventory, TICS-M modified telephone interview for cognitive status
\